PZ-1922

N/A

Report date: 2023/10/08 11:28:58
NMEFirst In Class

Base Information

Drug NamePZ-1922
Drug Alias NamePZ-1922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonistsSerotonin 3 (5-HT3) receptor antagonistsMonoamine oxidase B inhibitors
TargetsSerotonin 6 (5-HT6) receptorSerotonin 3 (5-HT3) receptorMonoamine oxidase B
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJagiellonian University Medical College
China Registration ClassN/A

Develop Information

Active CompaniesJagiellonian University Medical College
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A